Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 TGA Approves Setria Glutathione in Australia - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

TGA Approves Setria Glutathione in Australia

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Kyowa Hakko’s Setria glutathione is now available in Australia following approval by the country’s Therapeutics Goods Administration (TGA) for use as a therapeutically active ingredient.

The ingredient will be distributed exclusively in Australia by Trans Chem, a biotech specialist that sources and imports fine chemicals to Australian manufacturers. TGA approval of Setria glutathione was received in October, after a milestone clinical trial of the master antioxidant showed positive results, which were published in the European Journal of Nutrition. Setria meets the current United States Pharmacopeial (USP) Convention Standards and is available as a dietary supplement in the U.S., Canada, Mexico and select countries in Europe and Asia.

Glutathione is a potent and natural antioxidant. Kyowa Hakko uses a patented fermentation technology to manufacture a pure form of glutathione. Called nature’s “master antioxidant,” glutathione replenishes the body’s stores helping to protect cells from oxidative stress and harmful toxins associated with free radicals.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics